Armata Pharmaceuticals (ARMP) Interest & Investment Income (2018 - 2024)
Armata Pharmaceuticals (ARMP) posted Interest & Investment Income of $221000.0 for Q2 2024, up 325.0% sequentially from $52000.0 in Q1 2024, and up 380.43% YoY from $46000.0 in Q3 2023.
Armata Pharmaceuticals (ARMP) Interest & Investment Income (2018 - 2024) Analysis & Trends
Armata Pharmaceuticals has reported Interest & Investment Income for 7 years, with the latest figure at $221000.0 in Q2 2024.
- Quarterly Interest & Investment Income rose 380.43% year-over-year to $221000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $388000.0 (up 345.98% YoY) and the FY2023 annual result came in at $179000.0, up 517.24% from the prior year.
- Interest & Investment Income rose to $221000.0 in Q2 2024 per ARMP's latest filing, from $52000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $221000.0 in Q2 2024 and troughed at $1000.0 in Q4 2021.
- A 5-year average of $32125.0 and a median of $11500.0 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2020 and 2023: Interest & Investment Income sank 95.83% in 2020, then surged 1700.0% in 2023.
- Over 5 years, Interest & Investment Income stood at $4000.0 in 2020, then slumped by 75.0% to $1000.0 in 2021, then surged by 1300.0% to $14000.0 in 2022, then surged by 385.71% to $68000.0 in 2023, then jumped by 225.0% to $221000.0 in 2024.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $221000.0, $52000.0, and $68000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 221,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 47,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 28,000.00 |
| Mar 31, 2019 | 48,000.00 |